Because depletion of CAFs can reduce the stroma and enhance drug delivery to cancer cells, a combination therapy of NIR-PIT targeting CAFs and chemotherapy with GEM was secondly investigated in a murine PDAC model. The gene discussed is TBX1; the disease is cancer.